| Previous Close | 60.03 |
| Open | 59.98 |
| Bid | 0.00 x 3200 |
| Ask | 0.00 x 1100 |
| Day's Range | 59.95 - 60.84 |
| 52 Week Range | 45.76 - 68.34 |
| Volume | 3,386,740 |
| Avg. Volume | 10,043,460 |
| Market Cap | 137.116B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 |
| Earnings Date | Nov. 05, 2020 |
| Forward Dividend & Yield | 1.80 (2.97%) |
| Ex-Dividend Date | Oct. 01, 2020 |
| 1y Target Est | 73.69 |
- Zacks
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
- Zacks
Prothena (PRTA) to Advance Parkinson's Disease Drug to Phase II
Prothena (PRTA) and partner Roche (RHHBY) plan to advance prasinezumab into a phase IIb study in patients with early Parkinson's disease.
- Zacks
Agios (AGIO) Withdraws Filing for Leukemia Drug Tibsovo in EU
Agios (AGIO) withdraws the regulatory filing for Tibsovo in Europe, which was developed to treat relapsed/refractory acute myeloid leukemia in adult patients with a susceptible IDH1 mutation.
© 2020 Verizon Media. All rights reserved.
